Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sinusitis Hevert (also known as Sinusitis Hevert SL) is an over-the-counter homeopathic complex remedy developed and manufactured by Hevert-Arzneimittel. It is indicated for the treatment of inflammatory diseases of the throat, nose, and paranasal sinuses (sinusitis), as well as common cold symptoms and rhinitis. The formulation consists of eleven homeopathic active ingredients: Apis mellifica, Baptisia tinctoria, Cinnabaris, Echinacea, Hepar sulfuris, Kalium bichromicum, Lachesis mutus, Luffa operculata, Mercurius bijodatus, Silicea, and Spongia officinalis. These ingredients work synergistically to exert anti-inflammatory, decongestant, and expectorant effects, helping to loosen stubborn mucus and clear the nasal passages. Sinusitis Hevert is formulated as oral tablets that dissolve in the mouth, making it suitable for adults, children, and infants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sinusitis Hevert.